• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡性结肠炎和克罗恩病中的补体抑制剂与免疫粘连素

Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.

作者信息

Potter B J, Brown D J, Watson A, Jewell D P

出版信息

Gut. 1980 Dec;21(12):1030-4. doi: 10.1136/gut.21.12.1030.

DOI:10.1136/gut.21.12.1030
PMID:6450718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1419393/
Abstract

The serum concentrations of the complement inactivators C1INH, C3bINA and beta 1H have been determined in patients with ulcerative colitis and Crohn's disease and their correlation with C3 and properdin factor B examined. The incidence of immunoconglutinins (1K) in these patients was investigated. Raised serum concentrations of C1INH and C3bINA have been found in patients with active disease, but no significant alteration was found in serum concentration of beta 1H. An increasing incidence of positive 1K titres was found with increased length of disease history. These results suggest continuing complement activation in these diseases.

摘要

已测定溃疡性结肠炎和克罗恩病患者血清中补体灭活剂C1INH、C3bINA和β1H的浓度,并检测了它们与C3和备解素因子B的相关性。对这些患者中免疫粘连素(1K)的发生率进行了研究。发现活动期患者血清中C1INH和C3bINA浓度升高,但β1H血清浓度未发现明显变化。随着病程延长,1K滴度阳性的发生率增加。这些结果提示这些疾病中补体持续激活。

相似文献

1
Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病中的补体抑制剂与免疫粘连素
Gut. 1980 Dec;21(12):1030-4. doi: 10.1136/gut.21.12.1030.
2
Humoral immune system in inflammatory bowel disease: I. Complement levels.炎症性肠病中的体液免疫系统:I. 补体水平。
Gut. 1977 Sep;18(9):749-53. doi: 10.1136/gut.18.9.749.
3
Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.C3b灭活因子和β1H球蛋白在系统性红斑狼疮中对备解素放大环调节作用的相对重要性
Clin Exp Immunol. 1979 Jun;36(3):408-14.
4
Control of complement activation in membranous and membranoproliferative glomerulonephritis.膜性和膜增生性肾小球肾炎中补体激活的控制
Kidney Int. 1980 Apr;17(4):535-44. doi: 10.1038/ki.1980.62.
5
Control of serum C3 levels by beta 1H and C3b inactivator.β1H和C3b灭活剂对血清C3水平的调控
J Lab Clin Med. 1980 Jun;95(6):905-17.
6
Evidence for glomerular modulation of complement activation.肾小球对补体激活调节作用的证据。
J Clin Lab Immunol. 1979 Apr;2(1):9-13.
7
Complement alterations in inflammatory bowel disease.炎症性肠病中的补体改变。
Gastroenterology. 1979 Jun;76(6):1374-9.
8
High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitis.属于补体系统的两种急性期蛋白,即血清C3和C1抑制因子水平处于高正常范围,在克罗恩病患者中比溃疡性结肠炎患者中更频繁出现。
Dig Dis Sci. 2003 Jun;48(6):1186-92. doi: 10.1023/a:1023793502456.
9
Serum C3 and C4 complement components in ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病中的血清C3和C4补体成分
Digestion. 1975;13(1-2):100-3. doi: 10.1159/000197698.
10
Acute-phase reactant proteins and complement components and inhibitors in patients with ovarian cancer.卵巢癌患者的急性期反应蛋白、补体成分及抑制剂
Gynecol Oncol. 1981 Jun;11(3):288-98. doi: 10.1016/0090-8258(81)90042-1.

引用本文的文献

1
Proteomic Analysis of Potential Targets for Non-Response to Infliximab in Patients With Ulcerative Colitis.溃疡性结肠炎患者对英夫利昔单抗无反应的潜在靶点的蛋白质组学分析
Front Pharmacol. 2022 Jun 13;13:905133. doi: 10.3389/fphar.2022.905133. eCollection 2022.
2
Low CFB expression is independently associated with poor overall and disease-free survival in patients with lung adenocarcinoma.低补体因子B(CFB)表达与肺腺癌患者的总生存期和无病生存期较差独立相关。
Oncol Lett. 2021 Jun;21(6):478. doi: 10.3892/ol.2021.12739. Epub 2021 Apr 19.
3
Autoantibodies Against C3b-Functional Consequences and Disease Relevance.针对 C3b 功能后果的自身抗体及其与疾病的相关性。
Front Immunol. 2019 Jan 29;10:64. doi: 10.3389/fimmu.2019.00064. eCollection 2019.
4
A cross-ethnic survey of CFB and SLC44A4, Indian ulcerative colitis GWAS hits, underscores their potential role in disease susceptibility.一项针对补体因子B(CFB)和溶质载体家族44成员4(SLC44A4)这两个印度溃疡性结肠炎全基因组关联研究(GWAS)发现位点的跨种族调查,强调了它们在疾病易感性中的潜在作用。
Eur J Hum Genet. 2016 Jan;25(1):111-122. doi: 10.1038/ejhg.2016.131. Epub 2016 Oct 19.
5
Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis.狼疮性肾炎患者中抗补体成分C3自身抗体的功能特性
J Biol Chem. 2015 Oct 16;290(42):25343-55. doi: 10.1074/jbc.M115.647008. Epub 2015 Aug 5.
6
Subnormal activation of phagocytes by complement in chronic inflammatory bowel disease? Neutrophil chemotaxis to complement split product C5a.慢性炎症性肠病中补体对吞噬细胞的激活不足?中性粒细胞对补体裂解产物C5a的趋化作用。
Gut. 1984 Jul;25(7):737-42. doi: 10.1136/gut.25.7.737.
7
Familial occurrence of complement dysfunction in Crohn's disease: correlation with intestinal symptoms and hypercatabolism of complement.克罗恩病中补体功能障碍的家族性发生:与肠道症状及补体高分解代谢的相关性
Gut. 1985 Feb;26(2):151-7. doi: 10.1136/gut.26.2.151.
8
Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophils.慢性炎症性肠病中花生四烯酸的异常代谢:活化中性粒细胞中白三烯B4释放增加。
Gut. 1987 Feb;28(2):181-5. doi: 10.1136/gut.28.2.181.
9
The immunology of inflammatory bowel disease.炎症性肠病的免疫学
Springer Semin Immunopathol. 1990;12(2-3):251-68. doi: 10.1007/BF00197510.

本文引用的文献

1
Cortisone in ulcerative colitis; final report on a therapeutic trial.可的松治疗溃疡性结肠炎;一项治疗试验的最终报告
Br Med J. 1955 Oct 29;2(4947):1041-8. doi: 10.1136/bmj.2.4947.1041.
2
Positive epinephrine skin test for "circulating endotoxin" in inflammatory disease of the intestine.肠道炎性疾病中“循环内毒素”的肾上腺素皮肤试验呈阳性。
Am J Clin Pathol. 1965 Dec;44(6):642-7. doi: 10.1093/ajcp/44.6.642.
3
Decreased properdin activity in acute glomerulonephritis.急性肾小球肾炎中备解素活性降低。
Int Arch Allergy Appl Immunol. 1969;36(6):592-8. doi: 10.1159/000230780.
4
Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus.急性肾小球肾炎和系统性红斑狼疮中补体成分的系列变化
Clin Exp Immunol. 1969 Feb;4(2):191-202.
5
Short-term course and prognosis of Crohn's disease.克罗恩病的短期病程及预后
Gut. 1974 Jun;15(6):435-43. doi: 10.1136/gut.15.6.435.
6
Proceedings: Serum complement components C3 and C4 in inflammatory bowel disease.论文集:炎症性肠病中的血清补体成分C3和C4
Gut. 1974 Oct;15(10):835.
7
Circulating immune complexes in inflammatory bowel disease.炎症性肠病中的循环免疫复合物
Clin Exp Immunol. 1973 Jun;14(2):219-26.
8
Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.补体系统与内毒素脂多糖的相互作用:六种末端补体成分各自的消耗情况。
J Exp Med. 1968 Nov 1;128(5):1049-57. doi: 10.1084/jem.128.5.1049.
9
Evidence of cytotoxicity in ulcerative colitis from immunofluorescent staining of the rectal mucosa.直肠黏膜免疫荧光染色显示溃疡性结肠炎细胞毒性的证据。
Lancet. 1974 May 25;1(7865):1014-7. doi: 10.1016/s0140-6736(74)90416-4.
10
Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease, and ulcerative colitis.成人乳糜泻、克罗恩病和溃疡性结肠炎中补体结合免疫复合物的证据。
Lancet. 1973 Feb 24;1(7800):402-3. doi: 10.1016/s0140-6736(73)90254-7.